Genmab A/S

Genmab A/S Stock

77.52P/E
€25.97BMarket capitalisation
US$37.94Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

Genmab A/S is registered in the following country: Denmark (Exchange: DKCSE).

Key metrics

Key metrics and master data for the Genmab A/S stock.

Market capitalisation
€25.97B
P/E
77.52
P/B
5.07
P/S
26.46
P/CF
37.13
Issued shares 62M Units

Return

Here you can see the performance of the Genmab A/S stock.

PeriodPerfor­mance
1 Week-0.92 %
1 Month+42.17 %
3 Months+67.50 %
6 Months+109.05 %
1 Year+84.32 %
YTD+69.66 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Genmab A/S share.

DateRatio
No data available.

Which ETF contains the Genmab A/S stock?

The Genmab A/S stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Genmab A/S has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Genmab A/S stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.